Perionyxis caused by Fusarium verticillioides in an immunocompetent patient;A propos d'un cas de perionyxis a Fusarium verticillioides chez une patiente immunocompetente

Journal de Mycologie Medicale

Volumn 10, Issue 1, 2000, Pages 39-42

  Michel Nguyen, A ^a   Favel, A ^b   Guelain, M ^a   Chastin, C ^b   Devant, O ^a   Regli, P ^b   Berbis, P ^a   Penaud, A ^a  

^a HÔPITAL NORD   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Fusarium verticillioides; Perionyxis; Susceptibility

Indexed keywords

AMOROLFINE; AMPHOTERICIN B; CICLOPIROX; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE;

AGED; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; DRUG SENSITIVITY; FEMALE; FUSARIUM; HUMAN; MINIMUM INHIBITORY CONCENTRATION; ONYCHOMYCOSIS; PARONYCHIA;

EID: 0034016557     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Biodisk AB. Etest technical guide n° 4 : antifungal susceptibility testing of yeasts. AB Biodisk, 1995, Solna, Suède.
2. Baran R, Tosti A, Piraccini BM. Uncommon clinical pattern of Fusarium nail infection : report of three cases. Br J Dermatol 1997; 136:424-7.
3. Baran R, Hay RJ, Tosti A, Haneke E. A new classification of onychomycosis. Br J Dermatol 1998;139:567-71.
4. Booth C. The genus Fusarium. Commonwealth Mycological Institute Ed., Kew Surrey, 1971, pp. 46-53.
5. Chabasse D. Les nouveaux champignons opportunistes apparus en médecine. J Mycol Méd 1994;4:9-28.
6. Clayton YM. Clinical and mycological diagnostic aspects of onychomycoses and dermatomycoses. Clin Exp Dermatol 1992;17 (suppl) : 37-40.
7. Contet-Audonneau N, Salvini O, Basile AM, Percebois G. Les onychomycoses à moisissures. Nouv Dermatol 1995;14:330-40.
8. De Vroey C, Desmet P, Li ZQ, Mukamurangwa P, Raes-Wuytack C. Further studies on the in vitro antifungal activity of amorolfine. Mycoses 1996;39:41-4.
9. Dordain-Bigot ML, Baran R, Baixench MT, Bazex J. Onychomycoses à Fusarium. Ann Dermatol Venereol 1996;123:191-3.
10. Elewski BE. Clinical pearl : proximal white subungual onychomycosis in AIDS. J Am Acad Dermatol 1993;29:631-2.
11. Elewski BE. Large-scale epidemiological study of the causal agents of onychomycosis : mycological findings from the multicenter onychomycosis study of terbinafine. Arch Dermatol 1997;133:1317-8.
12. English MP. Nails and fungi. Br J Dermatol 1976;94:697-701.
13. st Congress of European Confederation of Medical Mycology, Nov. 26, 1993. Abstract p. 74, Institut Pasteur, Paris.
14. Makni F, Ayadis A, Makni S. Les onychomycoses à Sfax (Tunisie). J Mycol Méd 1998;8:108-11.
15. Pujol I, Guarro J, Gené J, Sala J. In vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains. J Antimicrobial Chemother 1997;39:163-7.
16. Romano C, Miracco C, Difonzo EM. Skin and nails infections due to Fusarium oxysporum in Tuscany, Italy. Mycoses 1998;41:433-7.
17. Speeleveld E, Gordts B, Van Landuyt HW, De Vroey C, Raes-Wuytack C. Susceptibility of clinical isolates of Fusarium to antifungal drugs. Mycoses 1996;39:37-40.
18. Summerbell RC, Kane J, Krajden S. Onychomycosis, tinea pedis and tinea manuum caused by non-dermatophytic filamentous fungi. Mycoses 1989;32:609-19.
19. Thomas PA, Geraldine P. Fungal keratitis due to Fusarium and other fungi. J Mycol Méd 1992;2:121-31.
20. Weinberg JM, Koestenblatt EK, Don PC, White SM, Stein MN, Bamji M. Proximal white subungual onychomycosis in the immuno-competent patient : report of two cases and review of the literature. Acta Derm Venereol 1999;79:81-95.